New steroidal anti-inflammatory antedrugs bind to macrophage glucocorticoid receptors and inhibit nitric oxide generation

This publication has 24 references indexed in Scilit:

• New steroidal anti-inflammatory antedrugs: Methyl 3,20-dioxo-9α-fluoro-11β,17α,21-trihydroxy-1,4-pregnadiene-16α-carboxylate and methyl 21-acetyloxy-3,20-dioxo-11β,17α-dihydroxy-9α-fluoro-1,4-pregnadiene-16α-carboxylate
  Steroids, 1997
• Nitric oxide: a key mediator in the early and late phase of carrageenan‐induced rat paw inflammation
  British Journal of Pharmacology, 1996
• Effect of chronic nitric oxide synthesis inhibition on the inflammatory responses induced by carrageenin in rats
  European Journal of Pharmacology, 1995
• Steroidal anti-inflammatory antedrugs: Synthesis and pharmacological evaluation of 16α-alkoxycarbonyl-17-deoxyprednisolone derivatives
  Steroids, 1995
• New Steroidal Antiinflammatory Antedrugs: Steroidal [16.alpha.,17.alpha.-d]-3'-Carbethoxyisoxazolines
  Journal of Medicinal Chemistry, 1995
• Receptor binding affinity and antiproliferative activity of new antiinflammatory antedrugs: 6-methoxycarbonyl prednisolone and its derivatives
  Steroids, 1994
• Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage.
  Circulation Research, 1993
• Nitric oxide: an endogenous modulator of leukocyte adhesion.
  Proceedings of the National Academy of Sciences, 1991
• Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo
  Acta Physiologica Scandinavica, 1990
• Flow-dependent coronary artery dilatation in humans.
  Circulation, 1989